NCT02025010 Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01983410 A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01965353 A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01955395 Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma Status COMPLETED Phase NA
NCT01954979 Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) Status COMPLETED Phase PHASE1/PHASE2
NCT01942837 Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01937468 Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01912963 Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer Status TERMINATED Phase PHASE2
NCT01894451 Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy Status COMPLETED Phase EARLY_PHASE1
NCT01890590 A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma Status RECRUITING Phase NA